Childhood acute lymphoblastic leukemia: 12 years of experience, using a Berlin–Frankfurt–Münster approach, in a Greek center-Reference-Cited by-同舟云学术

Childhood acute lymphoblastic leukemia: 12 years of experience, using a Berlin–Frankfurt–Münster approach, in a Greek center

Published:2014-06-27 Issue:1 Volume:56 Page:251-255
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ampatzidou Maria,Panagiotou John P.,Paterakis Georgios,Papadakis Vassilios,Papadhimitriou Stephanos I.,Parcharidou Agapi,Papargyri Sophia,Rigatou Efthimia,Avgerinou Georgia,Tsitsikas Konstantinos,Vasdekis Vassilios,Haidas Stavros,Polychronopoulou Sophia

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.916801

Reference16 articles.

1. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia

2. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

3. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Factors for Cardiotoxicity among Children with Cancer: Definition, Causes, and Diagnosis with Omics Technologies;Diagnostics;2023-05-26

2. The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols;Diagnostics;2023-04-28

3. Copy Number Alteration Profile Provides Additional Prognostic Value for Acute Lymphoblastic Leukemia Patients Treated on BFM Protocols;Cancers;2021-06-30

4. Insights from the Greek experience of the use of Blinatumomab in pediatric relapsed and refractory acute lymphoblastic leukemia patients;Neoplasma;2021

Proteomic analysis of cerebrospinal fluid in pediatric acute lymphoblastic leukemia patients: a pilot study

;OncoTargets and Therapy;2019-05